{"schema_version":"1","generated_at":"2026-11-13T11:28:53.508Z","data_as_of":null,"url":"https://www.findmykol.com/kol/susan-melin","json_url":"https://www.findmykol.com/kol/susan-melin/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"susan-melin","name":"Susan Melin","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Wake Forest University Health Sciences","institution_url":"https://www.findmykol.com/institution/wake-forest-university-health-sciences","city":"Winston Salem","state":"NC","region":{"label":"Southeast","url":"https://www.findmykol.com/region/southeast"}},"identifiers":{"npi":"1528042058","openalex":"A5113509208"},"summary":"Susan Melin is an Oncology physician affiliated with Wake Forest University Health Sciences. OpenAlex indexes 51 publications with 1,688 citations (h-index 19); ClinicalTrials.gov lists 1 registered study matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":51,"cited_by_count":1688,"h_index":19,"latest_activity_year":2025,"source":"works"},"trials":{"count":1,"shown":1,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT00637897","title":"Paricalcitol and Chemotherapy in Treating Women With Metastatic Breast Cancer","phase":"PHASE1","status":"COMPLETED","role":"Overall official","sponsor":"Wake Forest University Health Sciences","source_url":"https://clinicaltrials.gov/study/NCT00637897","trial_url":"https://www.findmykol.com/trial/NCT00637897"}],"source":"trials"},"payments":{"company_count":5,"program_years":{"first":2021,"last":null},"rows_total":16,"shown":3,"withheld":13,"rows":[{"payer":"JAZZ PHARMACEUTICALS INC.","program_year":2025,"amount_usd":125,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1528042058"},{"payer":"Eli Lilly","program_year":2024,"amount_usd":1666,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1528042058"},{"payer":"E.R. Squibb & Sons, L.L.C.","program_year":2024,"amount_usd":107.56,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1528042058"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1528042058","source":"payments"},"prescribing":{"data_year":2024,"areas_total":1,"areas_shown":1,"areas":[{"area":"Cancer & immunology","share_pct":100,"classes_total":3,"classes":[{"class":"Aromatase Inhibitor","setting":"prescribed","share_pct":61.4,"drugs":[{"name":"Letrozole","share_pct":64.8},{"name":"Anastrozole","share_pct":35.2}],"max_beneficiaries":null},{"class":"Estrogen Agonist/Antagonist","setting":"prescribed","share_pct":19.3,"drugs":[{"name":"Tamoxifen Citrate","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":0,"facility_pct":100},"source":"medicare"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Impact of Anti-Estrogen Therapy on Early Cardiovascular Referrals, Tests and Medications in Premenopausal Women with Operable Breast Cancer","year":2024,"journal":"Clinical Breast Cancer","source_url":"https://doi.org/10.1016/j.clbc.2024.02.006","status":"verified"},{"title":"Abstract P1-12-01: Impact of Anti-Estrogen Therapy on Early Vascular Referrals, Tests and Medications in Premenopausal Women with Operable Breast Cancer","year":2023,"journal":"Cancer Research","source_url":"https://doi.org/10.1158/1538-7445.sabcs22-p1-12-01","status":"verified"},{"title":"Statins and Left Ventricular Ejection Fraction Following Doxorubicin Treatment","year":2022,"journal":"NEJM Evidence","source_url":"https://doi.org/10.1056/evidoa2200097","status":"verified"},{"title":"Machine learning models for accurate pretreatment prediction of chemotherapy associated LV dysfunction in patients with breast cancer and lymphoma receiving chemotherapy (WF-98213 PREVENT and CCCWFU9912 DETECT IV).","year":2022,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2022.40.16_suppl.1553","status":"verified"},{"title":"Randomized trial of atorvastatin during and following receipt of doxorubicin for breast cancer and lymphoma (WF-98213).","year":2022,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2022.40.16_suppl.12072","status":"verified"}],"source":"works"},"contact":{"address_1":"MEDICAL CENTER BLVD","city":"Winston Salem","state":"NC","zip":"271570001","phone":"336-716-2255","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1528042058","source":"identity"},"similar":[{"name":"Anca Safta","slug":"anca-safta","institution":"Wake Forest University Health Sciences","specialty":"Pediatric Gastroenterology","url":"https://www.findmykol.com/kol/anca-safta","json_url":"https://www.findmykol.com/kol/anca-safta/profile.json"},{"name":"Ruth Benca","slug":"ruth-benca","institution":"Wake Forest University Health Sciences","specialty":"Psychiatry","url":"https://www.findmykol.com/kol/ruth-benca","json_url":"https://www.findmykol.com/kol/ruth-benca/profile.json"},{"name":"Jeff Williamson","slug":"jeff-williamson","institution":"Wake Forest University Health Sciences","specialty":"Geriatric Medicine","url":"https://www.findmykol.com/kol/jeff-williamson","json_url":"https://www.findmykol.com/kol/jeff-williamson/profile.json"},{"name":"Joseph Yeboah","slug":"joseph-yeboah","institution":"Wake Forest University Health Sciences","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/joseph-yeboah","json_url":"https://www.findmykol.com/kol/joseph-yeboah/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":13,"publications":45}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2016-05-13","collected_at":"2026-11-06T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}